Skip to main content
SpringerLink
Log in

Immunohistochemical localization of lysosomal cathepsin D in schwannomas

  • Original Article
  • Published:
Brain Tumor Pathology Aims and scope Submit manuscript

Abstract

The immunohistochemical localization of cathepsin D (CD) was demonstrated for the first time in 54 schwannomas (32 intra- and 22 extracranial; 47 benign and 7 malignant) and 5 normal nerve fibers. Granular or vesicular CD-reactive structures were observed in all normal Schwann cells. All tumors contained CD-reactive tumor cells, although the population of CD-reactive tumor cells, the density, intracellular localization, and morphology of CD-reactive structures, and the intensity of CD immunore-activity varied from case to case, portion to portion, and cell to cell, differing variously from those in normal Schwann cells. The variations were greater in malignant than in benign schwannomas. In mildly degenerate tumor cells, CD immunoreactivity was increased, possibly in response to the increased intracellular degenerate proteins, suggesting that the mechanism of induction of lysosomal proteases preserved in normal cells is not affected by the process of neoplastic transformation. In lesions of severe degeneration or necrosis, CD immunoreactivity was lost in most tumor cells but was strong in macrophages invading the lesions and perivascular regions. CD immunoreactivity was observed at various intensities in tumor cells in the Antoni type A area but not in most tumor cells in the Antoni type B area, suggesting that Antoni type B lesions show degenerative changes. The presence of CD-reactive tumor cells in all tumors examined and strong CD immunoreactivity observed at the invasion front of tumors in some cases of benign or malignant schwannoma suggests the possible role of CD in tumor invasion in some cases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Kirschke H, Barrett AJ (1987) Chemistry of lysosomal proteases. In: Glauman, H, Ballard FJ (eds) Lysosomes: their role in protein breakdown, Academic London, pp 193–237

    Google Scholar 

  2. Conner GE, Blobel G., Erickson AH (1987) Biogenesis of lysosomal proteinases: polypeptide chain. In: Glauman H, Ballard FJ (eds) Lysosomes: their role in protein breakdown. Academic, London, pp 151–161

    Google Scholar 

  3. Sivapalvathi m, Sawaya R, Chintala SK et al. (1996) Expression of cathepsin D during the progression of human gliomas. Neurosci Lett 208:171–174

    Article  Google Scholar 

  4. Warich M, von Bossanyi P, Dietmann K (1995) Expression of cathepsin D in human astrocytic neoplasias. Gen Diagn Pathol 141:93–96

    PubMed  CAS  Google Scholar 

  5. Robson DK, Ironside JW, Reid WA et al. (1990) Immunolocalization of cathepsin D in the human central nervous system and central nervous system neoplasms. Neuropathol Appl Neurobiol 16:39–44

    PubMed  CAS  Google Scholar 

  6. Gottschalk J, Goebel S, Jautzke G et al. (1992) Influence of preoperative dexamethasone therapy on proliferating cell nuclear antigen (PCNA) expression in comparison to other parameters in meningiomas. Histol Histopathol 7:653–661

    PubMed  CAS  Google Scholar 

  7. Gohring UJ, Scharl A, Thelen U et al. (1996) Comparative prognostic value of cathepsin D and urokinase plasminogen activator, detected by immunohistochemistry, in primary breast carcinoma. Anticancer Res 16:1011–1018

    PubMed  CAS  Google Scholar 

  8. Leto G, Gebbia N, Rausa L et al. (1992) Cathepsin D in the malignant progression of neoplastic diseases (review). Anticancer Res 12:235–240

    PubMed  CAS  Google Scholar 

  9. Wistanley JH, Leinstar SJ, Cooke TG et al. (1993) Prognostic significance of cathepsin D in patients with breast cancer. Br J Cancer 67:767–772

    Google Scholar 

  10. Saku T, Sakai H, Tsuda N et al. (1990) Cathepsins D and E in normal, metaplastic, dysplastic, and carcinomatous gastric tissue: an immunohistochemical study. Gut 31:1250–1255

    PubMed  CAS  Google Scholar 

  11. Valentin AM, Pirreli M, Armentano R et al. (1996) The immuno-histochemical expression of cathepsin D in colorectal cancer. Anticancer Res 16:77–80

    Google Scholar 

  12. Holm R, Tanum G (1996) Evaluation of the prognostic significance of nm23/NDP kinase and cathepsin D in anal carcinomas. An immunohistochemical study. Virchows Arch 428:85–89

    Article  PubMed  CAS  Google Scholar 

  13. Resnick JM, Uhrman D, Niehans GA et al. (1995) Cervical lymph node status and survival in laryngeal carcinoma. Ann Otol Rhinol Laryngol 104:685–694

    PubMed  CAS  Google Scholar 

  14. Dickson AJ, Fox SB, Newcomb PV et al. (1995) An immunohistochemical and prognostic evaluation of cathepsin D expression in 105 bladder carcinomas. J Urol 154:237

    Article  Google Scholar 

  15. Moul JW, Maygarden SJ, Ware JL et al. (1996) Cathepsin D and epidermal growth factor receptor immunohistochemistry does not predict recurrence of prostate cancer in patients undergoing radical prostatectomy. J Urol 155:982–985

    Article  PubMed  CAS  Google Scholar 

  16. Henzen-Logmans SC, Fieret EJ, Berns EM et al. (1994) Ki-67 staining in benign, borderline, malignant primary and metastatic ovarian tumors: correlation with steroid receptors, epidermal growth factor receptor and cathepsin D. Int J Cancer 57:468–472

    PubMed  CAS  Google Scholar 

  17. Nielsen AL, Nyholm HC (1995) Endometrial adenocarcinoma of endometrioid subtype with squamous differentiation: an immunohistochemical study of MIB-1 (Ki-67 paraffin), cathepsin D, and c-erbB-2 protein (p185). Int J Gynecol Pathol 14:230–234

    Article  PubMed  CAS  Google Scholar 

  18. Kristensen GB, Holm R, Abeler VM et al. (1996) Evaluation of the prognostic significance of cathepsin D, epidermal growth factor receptor and c-erbB-2 in early cervical squamous carcinoma. An immunohistochemical study. Cancer 78:433–440

    Article  PubMed  CAS  Google Scholar 

  19. Holm R, Hoie J, Kaalhus O et al. (1995) Immunohistochemical detection of nm23/NDP kinase and cathepsin D in medullary carcinomas of the thyroid gland. Virchows Arch 427:289–294

    Article  PubMed  CAS  Google Scholar 

  20. Vigniswaran N, Muller S, DeRose P et al. (1994) Cathepsin D and tumor associated antigen DF3 in salivary gland neoplasia. Differential diagnostic and prognostic applications. Pathol Res Pract 190:1174–1184

    Google Scholar 

  21. Kageshita T, Yoshii A, Kimura T et al. (1955) Biochemical and immunohistochemical analysis of cathepsin B, H, L and D in human melanocytic tumors. Arch Dermatol Res 287:266–272

    Article  Google Scholar 

  22. Maygarden SJ, Novotony DB, Moul JW et al. (1994) Evaluation of cathepsin D and epidermal growth factor receptor in prostate carcinoma. Mod Pathol 7:930–936

    PubMed  CAS  Google Scholar 

  23. Burger PC, Scheithauer BW, Vogel FS (1991) Intracranial Schwann cell neoplasms. In: Burger PC, Scheithauer BW, Vogel FS (eds) Surgical pathology of the nervous system and its coverings. 3rd ed. Churchill Livingstone, New York, pp 398–405

    Google Scholar 

  24. Enzinger FM, Weiss SW (1995) Malignant tumors of the peripheral nerves In: Enzinger FM, Weiss SW (eds) Soft tissue tumors. 3rd ed. Mosby, St. Louis, pp 889–928

    Google Scholar 

  25. Sloane BF, Lah TT, Day NA et al. (1986) Tumor cysteine proteinases and their inhibitors. In: Turk V (ed) Cysteine proteinases and their inhibitors Proc Int Symp Portoroz 1985 de Gruyter, Berlin, pp 729–749

    Google Scholar 

  26. Menrad A, Speicher D, Wacker J et al. (1993) Biochemical and functional characterization of aminopeptidase N expressed by human melanoma cells. Cancer Res 53:1450–1455

    PubMed  CAS  Google Scholar 

  27. Ii K, Hizawa K, Kominami E et al. (1985) Different immunolocalizations of cathepsins B, H and L in the liver. J Histochem Cytochem 33:1173–1175

    PubMed  CAS  Google Scholar 

  28. Ii K, Hizawa K, Nonaka I et al. (1986) Abnormal increases of lysosomal cysteine proteinases in rimmed vacuoles in the skeletal muscle. Am J Pathol 122:193–198

    PubMed  CAS  Google Scholar 

  29. Ii K, Ito H, Kominami E et al. (1993) Abnormal distribution of cathepsin proteinases and endogenous inhibitors (cystatins) in the hippocampus of patients with Alzheimer's disease, parkinsonism-dementia complex on Guam, and senile dementia and in the aged. Virchows Arch A 423:185–194

    Article  CAS  Google Scholar 

  30. Enzinger M, Weiss SW (1995) Neurilemmoma (benign schwannoma). In: Enzinger FM, Weiss SW (1995) Soft tissue tumors. Mosby, St. Louis, pp 829–838

    Google Scholar 

  31. Liotta LA (1986) Tumor invasion and metastases—role of extracellular matrix: Rhodes Memorial Award Lecture. Cancer Res 46:1–7

    PubMed  CAS  Google Scholar 

  32. Monteagudo C, Merino MJ, San-Juan J et al. (1990) Immunohistochemical distribution of type IV collagenase in normal, benign and malignant breast tissues. Am J Pathol 136:585–592

    PubMed  CAS  Google Scholar 

  33. Lacout A, Obled A, Christiane D et al. (1986) Postmortem localization of lysosomal peptide hydrolase, cathepsin B. In: Turk V (ed) Cysteine proteinases and their inhibitors. Proc Int Symp Portoroz 1985, de Gruyter, Berlin, pp 239–248

    Google Scholar 

  34. Etherington DJ, Maciewicz RA, Taylor MAJ et al. (1986) The role of collagen-degrading cysteine proteinases in connective tissue metabolism. In: Turk V (ed) (1986) Cysteine proteinases and their inhibitors. Proc Int Symp Portoroz 1985. de Gruyter, Berlin, pp 269–282

    Google Scholar 

  35. Machleidt W, Ritonja A, Povoic T et al. (1986) Human cathepsins B, H and L: Characterization by amino acid sequences and some kinetics of inhibition by the kininogens. In: Turk V (ed) Cysteine proteinases and their inhibitors. Proc Int Symp Portoroz 1985. de Gruyter, Berlin, pp 3–18

    Google Scholar 

  36. Sloane BF, Rozhin J, Moin K et al. (1989) Cathepsin B and endogenous cystein proteinase inhibitors in metastatic tumors. In: Katunuma N, Kominami E (eds) Intracellular proteolysis. Mechanisms and regulations. Proc 7th ICOP Meeting, Shimoda, pp 527–533

  37. Poole AR, Hembly RM, Dingle JT (1974) Cathepsin D in cartilage: the immunohistochemical demonstration of extracellular enzyme in normal and pathological condition. J Cell Sci 14:139–161

    PubMed  CAS  Google Scholar 

  38. Cravioto H (1969) The ultrastructure of acoustic nerve tumors. Acta Neuropathol (Berl) 12:116–140

    Article  CAS  Google Scholar 

  39. Nagai T, Todo S, Imashuku S (1986) Distinct isozyme patterns of cyclic nucleotide phosphodiesterase in human neuroblastoma and ganglioneuroma; a possible marker of differentiation of neural crest-derived tumors and Schwannoma cells. Jpn C Cancer Res 77:52–58

    CAS  Google Scholar 

  40. Rao JS, Baker JB, Morantz RA et al. (1990) Serpin inhibitors of urokinase and thrombin in normal rat brain and the 9L brain tumor: evidence for elevated expression of protease nexin I-like inhibitor and a novel sodium dodecyl sulfate-activated tumor antithrombin. Cancer Res 50:5039–5044

    PubMed  CAS  Google Scholar 

  41. Muir D, Manthorpe M (1992) Stromelysin generates a fibronectin fragment that inhibits Schwann cell proliferation. J Cell Biol 116:177–185

    Article  PubMed  CAS  Google Scholar 

  42. Yasumitsu H, Miyazaki Y, Umenishi F et al. (1992) Comparison of extracellular matrix-degrading activities between 64-kDa and 90-kDa gelatinases purified in inhibitor free forms from human Schwannoma cells. J Biochem (Tokyo) 111:74–80

    CAS  Google Scholar 

  43. Rao JS, Steck PA, Mohanam S et al. (1993) Elevated levels of M(r) 92,000 type IV collagenase in human brain tumors. Cancer Res 53:2208–2211

    PubMed  CAS  Google Scholar 

  44. Rao JS, Rayford A, Montaz RA et al. (1993) Increased levels of plasminogen activator inhibitor-1 (PAI-I) in human brain tumors. J Neurooncol 17:215–221

    Article  PubMed  CAS  Google Scholar 

  45. Bogaert ER, Cham SK, Zimmer C et al. (1994) Inhibition of collagenolytic activity relates to quantitative reduction of invasion in vitro in a c-Ha-ras transfected glial cell line. J Neurooncol 21:141–150

    Article  Google Scholar 

  46. Muller M, Hubbard SL, Fukuyama K et al. (1995) Characterization of a pineal region malignant rhabdoid tumor. Towards understanding brain tumor cell invasion. Pediatr Neurosurg 22:204–209

    Article  PubMed  CAS  Google Scholar 

  47. Matsuzawa K, Fukuyama K, Hubbard SL et al. (1996) Transfection of an invasive human astrocytoma cell line with a TIMP-1 cDNA: modulation of astrocytoma invasive potential. J Neuropathol Exp Neurol 55:88–96

    PubMed  CAS  Google Scholar 

  48. Yoshida E, Maruyama M, Sigiki M et al. (1994) Immunohistochemical demonstration of bikunin, a light chain of inter-alpha-trypsin inhibitor, in human brain tumors. Inflammation 18:589–596

    Article  PubMed  CAS  Google Scholar 

  49. Rempel SA, Rosenmlum ML, Mikkelsen T et al. (1994) Cathepsin B expression and localization in glioma progression and invasion. Cancer Res 54:6027–6031

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. First Department of Pathology, School of Medicine, University of Tokushima, 3-18-15, Kuramoto-Cho, 770, Tokushima, Japan

    Kunio Ii, Yang Peng & Takanori Hirose

  2. Department of Neurosurgery, School of Medicine, University of Tokushima, 770, Tokushima, Japan

    Seiji Kannuki & Keizo Matsumoto

Authors
  1. Kunio Ii
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yang Peng
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Takanori Hirose
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Seiji Kannuki
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Keizo Matsumoto
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ii, K., Peng, Y., Hirose, T. et al. Immunohistochemical localization of lysosomal cathepsin D in schwannomas. Brain Tumor Pathol 14, 87–95 (1997). https://doi.org/10.1007/BF02478876

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02478876

Key words

Search

Navigation